News Archive of New York Times- Biotechnology

ArticleAdded
Seeking Support, Biotech Food Companies Pledge Transparency07-29-13
A High-Tech Menagerie07-16-13
Cornell Scientist’s Quest: Perfect Broccoli07-10-13
After Patent Ruling, Availability of Gene Tests Could Broaden06-14-13
Connecticut Approves Labeling Genetically Modified Foods06-04-13
Modified Wheat Is Discovered in Oregon05-30-13
Executive at Monsanto Wins Global Food Honor06-20-13
Monsanto Executive Is Among World Food Prize Winners06-20-13
After DNA Patent Ruling, Availability of Genetic Tests Could Broaden06-14-13
Connecticut Approves Genetic Labeling06-04-13
Genetically Engineered Wheat Found in Oregon Field05-30-13
Taking a Chance on a Reverse Merger03-10-09
Biotech Firms, Billions at Risk, Lobby States to Limit Generics01-29-13
Building a $325,000 Burger05-14-13
A Dream of Trees Aglow at Night05-08-13
Double Helix Serves Double Duty01-29-13
Don’t Be Afraid of Genetic Modification03-10-13
Improper Efforts to Limit Competitive Drugs02-09-13
Deal Possible for Life Technologies01-19-13
A New Class of Cancer Drugs May Be Less Toxic06-01-12
Craig Venter’s Bugs Might Save the World06-03-12
White House Promotes a Bioeconomy04-26-12
George Rathmann, Chief of Amgen, Dies at 8404-24-12
Monoclonal Antibodies, 197910-30-12
Coalition Drops Opposition to a Dow Engineered Crop09-12-12
Court Reaffirms Right of Myriad Genetics to Patent Genes08-16-12
Novel Blood Treatment Lures Athletes in Pain to Germany07-11-12
Study Backs Continuous Prostate Cancer Treatment06-03-12
Bid to Label Biotech Crops Is Trailing in California11-08-12
Craig Venter’s Bugs Might Save the World06-03-12
White House Promotes a Bioeconomy04-26-12
George Rathmann, Chief of Amgen, Dies at 8404-24-12
Court Reaffirms Right of Myriad Genetics to Patent Genes08-16-12
Novel Blood Treatment Lures Athletes in Pain to Germany07-11-12
Study Backs Continuous Prostate Cancer Treatment06-03-12
A New Class of Cancer Drugs May Be Less Toxic06-01-12
Bid to Label Biotech Crops Is Trailing in California11-08-12
Monoclonal Antibodies, 197910-30-12
Coalition Drops Opposition to a Dow Engineered Crop09-12-12
Monoclonal Antibodies, 197910-30-12
After Loss, the Fight to Label Modified Food Continues11-08-12
Coalition Drops Opposition to a Dow Engineered Crop09-12-12
Coalition Drops Opposition to Dow’s Genetically Engineered Crops09-11-12
Court Reaffirms Right of Myriad Genetics to Patent Genes08-16-12
Novel Blood Treatment Lures Athletes in Pain to Germany07-10-12
Athletes With Chronic Pain Turn to Novel Blood Treatment07-10-12
Human Genome Sciences Rejects A $2.59 Billion Bid From Glaxo04-20-12
Craig Venter’s Bugs Might Save the World06-03-12
Study Backs Continuous Prostate Cancer Treatment06-03-12
DEALBOOK; Human Genome Sciences Rejects A $2.59 Billion Bid From Glaxo04-20-12
White House Promotes a Bioeconomy04-26-12
George Rathmann, Chief of Amgen, Dies at 8404-23-12
Cost of Gene Sequencing Falls, Raising Hopes for Medical Advances03-07-12
Cancer Center, in Suit, Claims Ex-Official Took Research02-05-12
Life Sciences Development Rebounds in Central New Jersey01-31-12
Amgen and Watson to Work Together on Generic Drugs12-19-11
A Genome Deluge12-01-11
Drew Endy: Better Computing for the Things We Care About Most12-05-11
DNA Sequencing Caught in Deluge of Data11-30-11
China’s New Economic Plan Focuses on Raising Standards of Living03-05-11
Geron Is Shutting Down Its Stem Cell Clinical Trial11-14-11
Concerns Raised about Genetically Engineered Mosquitoes10-30-11
Entrepreneur Walk of Fame Opens in Cambridge09-29-11
When Cancer-Test Research Proves False07-11-11
Mutual Funds That Succeeded in a Tough 2nd Quarter07-09-11
DEALBOOK ONLINE12-22-10
Supercomputers Help Scientists Dig Deeper, See Farther, Share More04-25-11
New Urgency in Push For Radiation Drugs04-01-11
Human DNA Contamination Seen in Genome Databases02-16-11
Widespread Human DNA Contamination Seen in Genome Databases02-16-11
Biotech Tax Rate02-03-11
U.S. Approves Planting of Genetically Modified Alfalfa01-27-11
A Spotlight Big Enough for One Bad Guy at a Time06-08-10
Eugene Goldwasser, Developer of Anemia Drug, Dies at 8812-20-10
Duel Over Sugar Beet Seeds Could Create Shortage12-02-10
Biotech Crops Hit Legal Hurdle in European Union11-10-10
Setback Seen for E.U. Plan on Biotech Crops11-10-10
Setback Seen for EU Plan on Biotech Crops11-10-10
Gene Patent Ruling Is Criticized by Industry11-01-10
U.S. Says Genes Should Not Be Eligible for Patenting10-29-10
In a Policy Reversal, U.S. Says Genes Should Not Be Eligible for Patenting10-29-10
Genzyme Investors Are Urged to Reject Sanofi Offer10-22-10
Corporate Money Lets Chicago Researchers Avoid Stem Cell Limits10-21-10
New Lab Complexes Aim at a Biotech Future for New York10-19-10
E.U. Considers Easing Rules on Biotech Crops in Animal Feed10-08-10
Lessons From the Test Tube10-05-10
Fortunes Turn for Monsanto After Problems With Seeds10-04-10
Sanofi Makes Public a $18.5 Billion Bid for Genzyme08-29-10
Sanofi Offers $18.5 Billion for Genzyme08-29-10
Sanofi Reveals $18.5 Billion Offer for Genzyme08-29-10
Sanofi Reveals $18.5 Billion Offer to Take Over Genzyme08-29-10
Sanofi Reveals Its Bid for Genzyme08-29-10
Stryker and Massachusetts Settle Over Marketing Practices08-26-10
Genetics Pushes Canola Into the Wild08-09-10
Europe Clears Import of New Biotech Corn Varieties07-28-10
Exploring Algae as Fuel07-26-10
Europeans Seek to Ease Wide Ban on Biotech Crops07-07-10
Europe’s New Approach to Biotech Food07-07-10
Europe Seeks New Approach to Biotech Crops07-07-10
European Union Seeks New Approach to Biotech Crops07-07-10
THE GENOME AT 10; Awaiting the Genome Payoff06-15-10
Justices Back Monsanto on Biotech Seed Planting06-21-10
Court Backs Monsanto on Biotech Seed Sales06-21-10
Spanish Biotech Company Buys Talecris for $4 Billion06-07-10
Herbicide-Resistant Weeds06-01-10
Safety Rules Can’t Keep Up With Biotech Industry05-27-10
A Higher Bar for Pathogens, But Adherence Is an Issue05-27-10
Strong Biotech Safety Rules, but No Guarantees05-27-10
Toxic Weed Control05-12-10
Judge Invalidates Human Gene Patent03-29-10
After Patent on Genes Is Invalidated, Taking Stock03-30-10
Support Network Seeks to Grow Biotech Companies03-12-10
Justice Dept. Tells Farmers It Will Press Agriculture Industry on Antitrust03-12-10
E.U. Clears Biotech Potato for Cultivation03-03-10
Merck to Pay $7.2 Billion for Millipore03-01-10
After a Shooting, Colleagues Try to Regain Footing02-16-10
Staggered by a Shooting, a Small Biology Department Tries to Regain Its Footing02-16-10
A Previous Death at the Hand of Alabama Suspect02-14-10
A Previous Shooting Death at the Hand of Alabama Suspect02-14-10
A Previous Shooting Death at the Hands of Alabama Suspect02-14-10
At an Academic Pressure Cooker, a Setback Turns Deadly, Officials Say02-14-10
A New Way to Look for Diseases’ Genetic Roots01-26-10
At Genzyme, a Long View01-18-10
Biopharmaceutical Industry Is Banking on Boston01-05-10
Drugmakers’ Words in the Congressional Record11-30-09
Westchester Slowly Lures Biotech Companies10-21-09
Judge Rejects Approval of Biotech Sugar Beets09-23-09
Biotech Tries to Shrug Off Setbacks09-17-09
‘Non-GMO’ Seal Identifies Foods Mostly Biotech-Free08-29-09
Venture Capital, Still Seeking the Next Big Thing08-16-09
Cost of Decoding a Genome Is Lowered08-11-09
Partners Behind an MS Drug Take Their Dispute to Court08-07-09
Costly Drugs Known as Biologics Prompt Exclusivity Debate07-22-09
Canada Settles a Crop Trade Complaint Against Europe07-16-09
Helping Patients Get Back on All Four Feet07-05-09
Vaccine Maker Facing Possible Bankruptcy Wins Contract06-24-09
Despite Odds, Cities Race to Bet on Biotech06-11-09
Biotech Firm Ends Its Offer for Talecris06-09-09
Icahn Places Two Allies on the Biogen Idec Board06-04-09